Showing results (11-20 of 144) with videos related to
Sort By:
Pageof 15
Mayo Clinic Proceedings|November 3, 2009
Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agentsShernan G Holtan, Douglas J Creedon, Paul Haluska, et al.Mayo Clinic Proceedings|August 4, 2007
Diagnosis of obesity by primary care physicians and impact on obesity managementAditya Bardia, Shernan G Holtan, Jeffrey M Slezak, et al.Placenta|June 1, 2025
Placental growth factor enhances inflammatory toll-like receptor responses in syncytiotrophoblastsLaura F Newell, Shernan G Holtan, Leena Kadam, et al.Frontiers in Immunology|September 18, 2015
Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer TherapeuticsElizabeth Ann L Enninga, Wendy K Nevala, Shernan G Holtan, et al.Clinical & Developmental Immunology|March 16, 2011
Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanomaShernan G Holtan, Douglas J Creedon, Michael A Thompson, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 6, 2014
Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum periodElizabeth Ann L Enninga, Wendy K Nevala, Douglas J Creedon, et al.Transplantation and Cellular Therapy|May 11, 2024
Treatment-Responsive Acute Graft-versus-Host Disease after Post-Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical OutcomesShannon Herzog, Ryan Shanley, Shernan G Holtan, et al.Melanoma Research|July 26, 2016
Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanomaElizabeth Ann L Enninga, Wendy K Nevala, Shernan G Holtan, et al.Blood Cells, Molecules & Diseases|April 28, 2019
Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemiaLivia Hegerova, Fiona He, Nicole D Zantek, et al.Transplantation and Cellular Therapy|March 13, 2024
Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host DiseaseNajla El Jurdi, Shannon Herzog, Ryan Shanley, et al.Pageof 15